Looking to publish in JACC CardioOncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowJACC: CardioOncology is an open access specialist journal in the JACC family that advances cardiovascular care of cancer patients through innovative science and evidence-based knowledge. It publishes pre-clinical, translational, and clinical research, as well as best practices in cardio-oncology, covering areas such as disease mechanisms, model systems, therapeutics, epidemiology, precision medicine, prevention, amyloidosis, cardiovascular risk factors, heart failure, and vascular disease.
Looking to publish in JACC CardioOncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
JACC CardioOncology accepts the following article types. Click on an article type to view submission instructions.
Original Investigations
State-Of-The-Art Reviews
Primers In Cardio-Oncology
Long Form
Research Letters
Clinical Case Challenge
Letters To The Editor
Recent Publications
Sacubitril/Valsartan in Anthracycline-Treated Patients
Luigi Spadafora, Massimiliano Camilli
Rechallenge After Immune Checkpoint Inhibitors Myocarditis: Evidence and a Practical Framework
Joe-Elie Salem, Stephane Ederhy, Meiying Zhang, Marie Bretagne
The Future of Bleeding Risk Assessment in Cancer-Associated Thrombosis
Larissa Araújo de Lucena, Juliana Giorgi, Caroline Fischer-Bacca
Upper-Extremity Deep Vein Thrombosis in Cancer
António Araújo, José Costa, Ana Rodrigues
The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CM
Ronald M. Witteles
Frequently asked questions
How long does it take to publish?
For expedited review, the journal commits to a decision on suitability for expedited publication processing within 2 days and an initial decision within 14 days.
Reformat to JACC CardioOncology using Livewrite PremiumIs a cover letter required?
A cover letter is required at submission. It must state that the paper is not under consideration elsewhere, that none of the contents have been previously published, that all authors have read and approved the manuscript, and disclose any potential conflict of interest or state that none exists. The corresponding author should be specified. Ethical approval should be noted in the cover letter. For revisions or appeals, a rebuttal letter is required. A short paragraph explaining why the paper merits publication may be included, and authors may suggest potential reviewers or reviewers to avoid. Authors requesting expedited review should include the request and rationale in the cover letter.
Reformat to JACC CardioOncology using Livewrite PremiumWhat are the publication costs?
Article Publishing Charge: USD 4410 for full length articles and USD 1764 for short communications, excluding taxes.
Reformat to JACC CardioOncology using Livewrite Premium